Synagis and Trimethoprim drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Synagis and Trimethoprim. Common interactions include abdominal distension among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people who take Synagis and Trimethoprim have. It is created by eHealthMe based on reports of 20 people who take Synagis and Trimethoprim from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
20 people who take Synagis and Trimethoprim together, and have interactions are studied.
What is Synagis?
Synagis has active ingredients of palivizumab. eHealthMe is studying from 16,714 Synagis users for its effectiveness, alternative drugs and more.
What is Trimethoprim?
Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 5,857 Trimethoprim users for its effectiveness, alternative drugs and more.
Number of Synagis and Trimethoprim reports submitted per year:

Common Synagis and Trimethoprim drug interactions by gender *:
female:
- Abdominal distension
- Diarrhoea
- Pneumonitis
- Arrhythmia
- Sudden infant death syndrome
- Anaphylactoid reaction
- Central line infection
- Convulsions
- Echocardiogram abnormal
- Hepatic failure
male:
- Pyrexia
- Cough
- Heart rate increased
- Hypothalamo-pituitary disorder
- Oxygen saturation decreased
- Peripheral coldness
- Respiratory rate increased
- Skin discolouration
- Crying
- Injection site erythema
Common Synagis and Trimethoprim drug interactions by age *:
0-1:
- Hypothalamo-pituitary disorder
- Peripheral coldness
- Respiratory rate increased
- Skin discolouration
- Arrhythmia
- Cough
- Crying
- Dyspnoea
- Injection site erythema
- Injection site papule
2-9:
- Body temperature increased
- Excoriation
- Oxygen saturation decreased
- Viral infection
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
n/a
Common conditions people have *:
- Bronchopulmonary Dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type): 5 people, 25.00%
- Lung Disorder (lung disease): 2 people, 10.00%
- Premature Baby: 1 person, 5.00%
- Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 5.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
- Cardiomyopathy (weakening of the heart muscle): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Synagis and Trimethoprim?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Synagis (16,714 reports)
- Trimethoprim (5,857 reports)
Browse all drug interactions of Synagis and Trimethoprim:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Synagis side effects:
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 1,985 reports
- Fever: 1,747 reports
- Cough: 1,417 reports
- Pneumonia: 1,219 reports
- Death: 1,045 reports
- Breathing difficulty: 865 reports
- Nausea and vomiting: 675 reports
Browse all side effects of Synagis:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Trimethoprim side effects:
- Fever: 516 reports
- Urinary tract infection: 421 reports
- Nausea and vomiting: 401 reports
- Fatigue (feeling of tiredness): 357 reports
- Diarrhea: 349 reports
- Breathing difficulty: 344 reports
- Weakness: 337 reports
Browse all side effects of Trimethoprim:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Synagis interactions:
- Synagis and Furosemide: 562 reports
- Synagis and Albuterol: 479 reports
- Synagis and Spironolactone: 477 reports
- Synagis and Vitamin d: 333 reports
- Synagis and Zantac: 257 reports
- Synagis and Aspirin: 239 reports
- Synagis and Omeprazole: 225 reports
- Synagis and Lasix: 222 reports
- Synagis and Pulmicort: 219 reports
- Synagis and Albuterol sulfate: 216 reports
Browse all interactions between Synagis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Trimethoprim interactions:
- Trimethoprim and Omeprazole: 752 reports
- Trimethoprim and Acetaminophen: 695 reports
- Trimethoprim and Furosemide: 677 reports
- Trimethoprim and Sulfamethoxazole: 659 reports
- Trimethoprim and Aspirin: 646 reports
- Trimethoprim and Prednisone: 517 reports
- Trimethoprim and Simvastatin: 505 reports
- Trimethoprim and Lansoprazole: 463 reports
- Trimethoprim and Dexamethasone: 450 reports
- Trimethoprim and Folic acid: 430 reports
Browse all interactions between Trimethoprim and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on palivizumab and trimethoprim (the active ingredients of Synagis and Trimethoprim, respectively), and Synagis and Trimethoprim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Synagis and Trimethoprim.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gleevec and Bipolar Disorder - now
- Gleevec and Bi-Polar - now
- Metoclopramide and Aromasin drug interaction - now
- Caduet vs. Metolazone - 2 seconds ago
- Nasal Cavity Cancer and Joint Pain - 2 seconds ago
- Valacyclovir and Hordeolum - 5 seconds ago
- Amlodipine and Metipranolol drug interaction - 5 seconds ago
- Travatan and Myalgia Aggravated - 6 seconds ago
- Avastin and Necrolytic Migratory Erythema - 13 seconds ago
- Lutein and Glucophage Xr drug interaction - 16 seconds ago